home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
support.isiresearchsoft.com
/
support.isiresearchsoft.com.zip
/
support.isiresearchsoft.com
/
RefMan
/
capture
/
ovdrepfj.txt
< prev
next >
Wrap
Text File
|
1999-09-02
|
7KB
|
246 lines
<TITLE>OVID CD(Reprint) [FJ]</A> [<I>FJ]</I>] </TITLE><PRE>
1
UI - 94041636
AU - Flegel WA
AU - Baumstark MW
AU - Weinstock C
AU - Berg A
AU - Northoff H
IN - Abteilung fur Transfusionsmedizin, Universitat Ulm, Germany.
TI - Prevention of endotoxin-induced monokine release by human low- and
high-density lipoproteins and by apolipoprotein A-I.
SO - Infection & Immunity 1993 Dec;61(12):5140-6
JC - go7
SB - C
CP - United States
MH - Adult
MH - Monocytes/se [Secretion]
MH - *Monokines/se [Secretion]
MH - Support, Non-U.S. Gov't
MH - Tumor Necrosis Factor/se [Secretion]
AB - Interaction of endotoxin (lipopolysaccharide [LPS]) with human
lipoproteins is known to prevent the LPS-induced activation of human
monocytes and release of cytokines (monokines). LPS was exposed to
lipoprotein classes separated by ultracentrifugation and to
apolipoprotein A-I. Then monocytes were added, and the LPS
activation of monocytes was determined by measuring the induced
monokines. Failure of LPS to induce monokine release was called LPS
inactivation caused by lipoproteins or apolipoproteins. The LPS
inactivation is shown to be a function of low-density lipoproteins.
High-density lipoproteins inactivate LPS to a much lesser extent.
The very-low-density lipoproteins cannot inactivate LPS.
RN - (Lipopolysaccharides). 0 (Lipoproteins). 0 (Lipoproteins, HDL). 0
RN - (Lipoproteins, LDL). 0 (Monokines). 0 (Tumor Necrosis Factor).
IS - 0019-9567
PT - Journal Article.
LG - English
EM - 9402
2
UI - 94285755
AU - Blanchard V
AU - Raisman-Vozari R
AU - Vyas S
AU - Michel PP
AU - Javoy-Agid F
AU - Uhl G
AU - Agid Y
IN - INSERM U 289, Hopital de la Salpetriere, Paris, France.
TI - Differential expression of tyrosine hydroxylase and membrane
dopamine transporter genes in subpopulations of dopaminergic neurons
of the rat mesencephalon.
SO - Brain Research. Molecular Brain Research 1994 Mar;22(1-4):29-38
MH - Animal
MH - *Carrier Proteins/ge [Genetics]
MH - Comparative Study
MH - *Dopamine
MH - *Tyrosine Hydroxylase/ge [Genetics]
AB - Dopaminergic (DA) cells of the substantia nigra pars compacta (SNC)
and the ventral tegmental area (VTA) display differences in their
topography, biochemistry and susceptibility to pathological
processes. Neuronal dopamine concentration is regulated in large
part by tyrosine hydroxylase (TH), the rate-limiting enzyme of
dopamine synthesis, and by the dopamine reuptake system. In the
present study, TH protein, TH mRNA and dopamine membrane transporter
(DAT) mRNA were quantified at cellular level in 4 arbitrary
subregions of the rat ventral mesencephalon (lateral, middle, medial
SNC and VTA), using in situ hybridization and immunoautoradiography.
The distribution of labelling for TH protein and TH mRNA was almost
superimposable and close to that of DAT mRNA in mesencephalic
neurons.
RN - EC 1-14-16-2 (Tyrosine Hydroxylase). 0 (dopamine-binding protein).
RN - 0 (Carrier Proteins). 0 (Membrane Glycoproteins). 0 (Nerve Tissue
RN - Proteins). 51-61-6 (Dopamine).
UI - 098549316
AU - Holmes A H
AU - Greenough T C
AU - Balady G J
AU - Regnery R L
AU - Anderson B E
AU - O'Keane J C
AU - Fonger J D
AU - Mccrone E L
IN - Morton Hospital, 88 Washington Street, Taunton, MA 02780, USA.
TI - Bartonella henselae endocarditis in an immunocompetent adult.
SO - Clinical Infectious Diseases 21 (4). 1995. 1004-1007.
MH - CASE STUDY
MH - BARTONELLA HENSELAE
MH - HUMAN
MH - CAT OWNER
MH - AORTIC VALVE REPLACEMENT
MH - DIAGNOSIS
MH - LYMPHADENOPATHY
MH - GLOMERULONEPHRITIS
MH - MYOCARDITIS
MH - PETECHIAL RASH
MH - ANTIBODY TITER
AB - We describe a case of aggressive Bartonella henselae endocarditis in
an immunocompetent man who owned a cat. Aortic valve replacement was
required, and his infection was diagnosed by histology, serology,
and polymerase chain reaction analysis. The manifestations of his
disease included mediastinal lymphadenopathy, glomerulonephritis,
myocarditis, and a petechial rash; the unusual finding of a positive
titer of c-antineutrophil cytoplasmic antibodies was noted.
Serological titers were markedly elevated for gt 1 year despite
clinical improvement.
PT - Article.
UI - 83-10751
AU - Valverde, Olga
AU - Maldonado, Rafael
AU - Mico, Juan A
AU - Gibert-Rahola, Juan
TI - Study of the mechanisms involved in behavioral changes induced by
flunitrazepam in morphine withdrawal.
SO - Progress in Neuro-Psychopharmacology & Biological Psychiatry. Vol 29(5)
973-991, Sep 1995.
AB - Investigated the participation of noradrenergic, serotonergic and
benzodiazepine receptors on flunitrazepam (FZP)-modified morphine
withdrawal syndrome in male mice. (FZP) was associated to the
noradrenergic antagonists prazosin and propranolol, the serotonergic
agents ritanserine and p-chloro phenylalanine, the benzodiazepine
antagonist flumazenil, and the benzodiazepine partial inverse
agonist Ro 15-4513. A decrease in FZP-induced jumping behavior was
potentiated by prazosin, while ritanserine, flumazenil and Ro
15-4513 blocked this effect. FZP-induced increase on wet dog shake
frequency was partially reduced by flumazenil, and strongly
antagonized by ritanserine and Ro 15-4513. Noradrenergic and
serotonergic systems seem to be primarily implicated in the changes
induced on jumping and wet dog shakes respectively. These
modifications are induced through the activation of the
benzodiazepine receptors. (PsycINFO Database Copyright 1996 American
Psychological Assn, all rights reserved)
PT - Journal Article
UI - 83-07505
AU - El-Kadi, A O S
AU - Sharif, S I
TI - The role of 5-HT in the expression of morphine withdrawal in mice.
SO - Life Sciences. Vol 57(5) 511-516, Jun 1995.
AB - Studied the effects of methysergide (MET) and cyproheptadine (CYP)
on naloxone-precipitated withdrawal symptoms in morphine-dependent
male mice. The effects of these drugs were examined in normal Ss and
also Ss injected with 6-hydroxydopamine (6-OHDA) to destroy the
central noradrenergic neurones and to determine whether
5-hydroxytryptamine (5-HT) mediated effects are linked to
noradrenergic pathways. MET given 30 min before naloxone attenuated
withdrawal jumping, "wet dog" shakes, burrowing, and body weight
loss, but aggravated hypothermia. Similar effects were produced by
CYP on withdrawal, "wet dog" shakes, and hypothermia. Jumping was
aggravated by low doses and attenuated by higher doses of CYP. When
they were made morphine-dependent, Ss pretreated with 6-OHDA
developed higher degree of naloxone-induced withdrawal jumping than
nontreated Ss. MET further aggravated jumping but its effect on both
"wet dog" shakes and burrowing was lost in Ss exposed to 6-OHDA.
(PsycINFO Database Copyright 1996 American Psychological Assn, all
rights reserved)
PT - Journal Article
</PRE>